Royal Bank Of Canada Evogene Ltd. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.61 - $0.82 $256 - $344	420 Added 1024.39%	461 $0
Q1 2024 Nov 05, 2024	SELL	$0.7 - $0.98 $294 - $411	-420 Reduced 91.11%	41 $0
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.2 $2,004 - $4,296	-3,580 Reduced 98.87%	41 $0
Q1 2023 May 15, 2023	BUY	$0.59 - $0.86 $2,112 - $3,078	3,580 Added 8731.71%	3,621 $2,000
Q4 2022 Feb 14, 2023	SELL	$0.61 - $8.13 $76 - $1,016	-125 Reduced 75.3%	41 $0
Q1 2022 May 16, 2022	SELL	$1.09 - $1.83 $793 - $1,332	-728 Reduced 81.43%	166 $0
Q4 2021 Feb 14, 2022	SELL	$1.63 - $2.83 $130,825 - $227,138	-80,261 Reduced 98.9%	894 $1,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $3.45 $257 - $362	105 Added 0.13%	81,155 $214,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $5.02 $267,465 - $406,870	81,050 New	81,050 $277,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.